BRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87

Reuters10-09

BRIEF-Chance Pharma Enters Commercialization Deal With <a href="https://laohu8.com/S/000963">Huadong Medicine</a> For Respiratory Drug CXG87

Oct 9 (Reuters) - Chance Pharma:

CHANCE PHARMA ANNOUNCES COMMERCIALIZATION AGREEMENT WITH HUADONG MEDICINE FOR INNOVATIVE RESPIRATORY DRUG CXG87
CO WILL BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, REGISTRATION, MANUFACTURING, AND SUPPLY OF CXG87
TO GET AN UPFRONT FEE, MILESTONE PAYMENTS, & SHARE OF SALES PROFITS

Source text: ID:nCNWsvcwYa

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2574132274?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 17:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2574132274","market":"nz","top_or_hot":-1,"title":"BRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Chance Pharma Enters Commercialization Deal With <a href=\"https://laohu8.com/S/000963\">Huadong Medicine</a> For Respiratory Drug CXG87</title></head><body><p><span>Oct 9 (Reuters)</span><span> - </span>Chance Pharma:</p><ul><li><p>CHANCE PHARMA ANNOUNCES COMMERCIALIZATION AGREEMENT WITH HUADONG MEDICINE FOR INNOVATIVE RESPIRATORY DRUG CXG87</p></li><li><p>CO WILL BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, REGISTRATION, MANUFACTURING, AND SUPPLY OF CXG87</p></li><li><p>TO GET AN UPFRONT FEE, MILESTONE PAYMENTS, &amp; SHARE OF SALES PROFITS</p></li></ul><p>Source text: <span>ID:nCNWsvcwYa</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-09 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Chance Pharma Enters Commercialization Deal With <a href=\"https://laohu8.com/S/000963\">Huadong Medicine</a> For Respiratory Drug CXG87</title></head><body><p><span>Oct 9 (Reuters)</span><span> - </span>Chance Pharma:</p><ul><li><p>CHANCE PHARMA ANNOUNCES COMMERCIALIZATION AGREEMENT WITH HUADONG MEDICINE FOR INNOVATIVE RESPIRATORY DRUG CXG87</p></li><li><p>CO WILL BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, REGISTRATION, MANUFACTURING, AND SUPPLY OF CXG87</p></li><li><p>TO GET AN UPFRONT FEE, MILESTONE PAYMENTS, &amp; SHARE OF SALES PROFITS</p></li></ul><p>Source text: <span>ID:nCNWsvcwYa</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VQ18G:1","article_id":"2574132274","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2574132274","pubTimestamp":1760001278,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87Oct 9  - Chance Pharma:CHANCE PHARMA ANNOUNCES COMMERCIALIZATION AGREEMENT WITH HUADONG MEDICINE FOR INNOVATIVE RESPIRATORY DRUG CXG87CO WILL BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, REGISTRATION, MANUFACTURING, AND SUPPLY OF CXG87TO GET AN UPFRONT FEE, MILESTONE PAYMENTS, & SHARE OF SALES PROFITSSource text: ID:nCNWsvcwYa ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0183":"MSCI概念","BK0209":"零售","BK0132":"高送转概念","BK0188":"融资融券","000963":"华东医药","BK0196":"行业龙头","BK0175":"白马股","BK0187":"一线龙头","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD"},"translate_title":"BRIEF-Chance Pharma与华东医药就呼吸药物CXG87达成商业化协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000963":0.9},"content_text":"BRIEF-Chance Pharma Enters Commercialization Deal With Huadong Medicine For Respiratory Drug CXG87Oct 9 (Reuters) - Chance Pharma:CHANCE PHARMA ANNOUNCES COMMERCIALIZATION AGREEMENT WITH HUADONG MEDICINE FOR INNOVATIVE RESPIRATORY DRUG CXG87CO WILL BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, REGISTRATION, MANUFACTURING, AND SUPPLY OF CXG87TO GET AN UPFRONT FEE, MILESTONE PAYMENTS, & SHARE OF SALES PROFITSSource text: ID:nCNWsvcwYa ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2574132274","isCrawlerRequest":true}